2023 annual financial data
Travere Therapeutics 2023 Operating margin
Direct answer
Operating margin was -267.24%.
Operating income was -388,138,000 USD and net income was -111,399,000 USD.
Operating cash flow was -280,021,000 USD.
Get free Travere Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 145,238,000 USD
- Operating income
- -388,138,000 USD
- Net income
- -111,399,000 USD
- Operating cash flow
- -280,021,000 USD